Bio-Works Technologies AB (publ)

Stockholm Stock Exchange BIOWKS.ST

Bio-Works Technologies AB (publ) Shareholders' Equity for the year ending December 31, 2023

Bio-Works Technologies AB (publ) Shareholders' Equity is NA for the year ending December 31, 2023. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Stockholm Stock Exchange: BIOWKS.ST

Bio-Works Technologies AB (publ)

CEO	Ms. Lone Carlbom
IPO Date	Dec. 14, 2017
Location	Sweden
Headquarters	Virdings allé 18
Employees	35
Sector	Materials
Industries Plastics Biotechnology Chemicals & Advanced Materials Cleaning Supplies Containers & Packaging Personal Care Silver Vaccines

Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years